Varenicline Tablet, Film Coated
Product Images NDC 10135-809

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 10135-809). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

808-56 (808 56)

The text appears to be a description of a prescription medication in tablet form. The tablets contain 0.5mg of an ingredient, and it is recommended to refer to the enclosed medication guide for dispensing. The prescription seems to be for a specific patent with a code mentioned. The dosage and use instructions are also included in the detailed information.*

FDA Label Image

0809-56 (809 56)

FDA Label Image

Varenicline Figure 1 (Vareniclinetablets Figure1.jpg)

FDA Label Image

Varenicline Figure 2 (Vareniclinetablets Figure2.jpg)

FDA Label Image

Varenicline Figure 3 (Vareniclinetablets Figure3.jpg)

This text provides data on the efficacy of varenicline 1.0 mg BID compared to placebo over a period of 52 weeks in terms of continuous abstinence. The numbers indicate the percentage of individuals who remained abstinent from smoking at different time points during the study. This data may be useful for evaluating the effectiveness of varenicline in smoking cessation.*

FDA Label Image

Varenicline Structure (Vareniclinetablets Structure.jpg)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.